Innova Medical Group, a developer of rapid antigen test kits, completed the acquisition of Biological Laboratory, a clinical laboratory. Financial terms were not disclosed. "Today's acquisition of BIOLAB not only expands our R&D and clinical study management capability in the US but also our ability to supply diagnostic services at large-scale to both corporate and government clients. With BIOLAB, we increase our robust ability to provide diagnostic tests and to manufacture in-house diagnostic services. As Innova continues to grow our portfolio, BIOLAB will also assist to validate our partner products," Daniel Elliott, Innova Medical Group President and CEO.